申请人:Università Degli Studi Di Milano - Bicocca
公开号:EP2107054A1
公开(公告)日:2009-10-07
Inhibitors of the oncogenic tyrosine kinase ALK and of the Bcr-Abl mutant T315I Bcr-Abl, such as a compound of formula (I):
wherein Q, T, W, K, J, Y, X, Z are independently selected from C, N, S, O, provided that the corresponding rings are (hetero)aromatic;
n = 0 or 1;
q = 1 or 2;
pharmaceutical compositions containing the same and their use for the treatment of hyper-proliferative diseases.
抑制癌基因酪氨酸激酶ALK和Bcr-Abl突变体T315I Bcr-Abl的抑制剂,例如式(I)的化合物:
其中Q、T、W、K、J、Y、X、Z分别独立选择自C、N、S、O,前提是相应的环是(杂)芳香的;
n = 0或1;
q = 1或2;
含有相同化合物的药物组合物及其用于治疗高增殖性疾病。